tiprankstipranks
Trending News
More News >

Solvonis Therapeutics Announces Major Change in Voting Rights

Story Highlights
Solvonis Therapeutics Announces Major Change in Voting Rights

Don’t Miss TipRanks’ Half-Year Sale

An update from Graft Polymer (UK) PLC ( (GB:SVNS) ) is now available.

Solvonis Therapeutics PLC, a company involved in the pharmaceutical industry, has announced a significant change in its voting rights structure. William Potts has reduced his voting rights from 23.17% to 10.33% as of May 27, 2025, indicating a major shift in the company’s shareholder composition. This reduction could impact the company’s governance and decision-making processes, potentially affecting its strategic direction and stakeholder interests.

More about Graft Polymer (UK) PLC

Average Trading Volume: 14,599,829

Technical Sentiment Signal: Sell

Current Market Cap: £7.83M

Learn more about SVNS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1